Pharma, life sciences users leading New Jersey office leasing in 2022, JLL finds

From leasing to new construction, pharmaceutical and life sciences firms remained a leading force in New Jersey’s commercial real estate market through the first three quarters of 2022.

CBRE: Growth of pharma, biotech firms offers bright future for R&D space in N.J.

Despite years of consolidation by Big Pharma, New Jersey is one of a handful of markets that stand to gain from a promising growth trajectory for the U.S. life sciences sector.

Cunningham joins JLL life sciences team

By Joshua Burd JLL has bolstered its life sciences practice with the addition of John Cunningham, a broker with more than 30 years of experience in the state’s commercial real estate sector. The firm announced Tuesday that Cunningham has been…

Highs, lows of changing N.J. life sciences real estate market

A wave of acquisition and divestment activity is reshaping the life sciences industry — and its real estate needs — resulting in demands for new office space and a surplus of lab inventory. A new report reminds us that New Jersey is seeing many of those changes firsthand.

What makes N.J. attractive to growing companies?

A panel discussion hosted by NAIOP New Jersey focused on why and how “next-generation” companies are able to grow in the Garden State — and how the commercial real estate industry can support them in their growth.